Chimerix's gross profit is $190K, below the Healthcare sector average of $66B.
Get informed when a big investor buys or sells
+ FollowAs of Dec 31, 2024
Trailing 12 months ending Dec 31, 2024
Chimerix (CMRX) currently reports a gross profit of $190K as of December 2024. That compares with $-54M in the prior-year period — up 100.4% year over year. That is below the Healthcare sector average of $66B. Use the charts on this page to explore Chimerix's gross profit history and peer comparisons.
Chimerix's gross profit increased from $-54M to $190K — a 100.4% year-over-year increase (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Chimerix's gross profit of $190K is lower than the Healthcare sector average of $66B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
Chimerix reported $190K in gross profit as of December 2024. That compares with $-54M in the prior-year period — up 100.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current gross profit of $190K, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $66B. From there, open related valuation or income-statement pages for Chimerix, and consider following CMRX for alerts when major investors trade the stock.